4. Avandia - Top 10 Warnings and Recalls
Drug: Avandia
2006 sales: $3.4 billion
Manufacturer: GlaxoSmithKline
Safety concern: “black box;†heart failure, heart attack
Related Articles:
> New Avandia warning 'a muddle'. Report
> Avandia warning, comeback imminent? Report
> Avandia cleared FDA by one vote. Report
> Avandia, Actos don't boost death risk. Report
> FDA adds to drumbeat of bad news for Avandia. Report
> Expert committee says Avandia should stay. Report
> FDA expert wants Avandia withdrawn. Report
> Docs shunning Avandia in wake of safety study. Report
> Avandia risks exposed under deal to post data. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: